A general synthetic overview of the process of carcinogenesis is presented. The following points are discussed: the uniqueness of tumor disease with respect to other pathologies; tumors viewed as a pathology of the transduction system of signals that regulate the communal life of the cells of multicell organisms; the tumor as a genetic disease of somatic cells; carcinogenesis as a multistage event; the fundamental role of physiologic and pathologic rhythms of cell proliferation in the modulation of tumor incidence; mechanisms entailed in the maintenance of genome integrity; mechanisms involved in the protection of genome integrity from exogenous and endogenous causes of degradation of the genetic message.
AdelmanR., SaulR.L., AmesB.N.: Oxidative damage to DNA: relation to specied metabolic rate and life span. Proc. Natl. Acad. Sci. USA, 85: 2706–2708, 1988.
2.
AguilarF., HarrisC.C., SunT., HollsteinM., CeruttiP.: Geographic variation of p53 mutational profile in nonmalignant human liver. Science, 264: 1317–1319, 1994.
3.
ArmitageP.: Multistage models of carcinogenesis. Environ. Health Perspect., 63: 195–201, 1985.
4.
BulliardJ-L., CoxB., ElwoodJ.M.: Latitute gradients in melanoma incidence and mortality in the non-Maori population of New Zealand. Cancer Causes and Control, 5: 234–240, 1994.
DonehowerL.A., HarveyM., SlagleB.L., McArthurM., MontgomeryC.A.Jr., ButelJ.S., BradleyA.: Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumor. Nature, 356: 215–221, 1992.
9.
FearonE.R., VogelsteinB.: A genetic model for colorectal tumorigenesis. Cell, 61: 759–767, 1990.
10.
FishelR., LescoeM.K., RaoM.R.S., CopelandN.G., JenkinsN.A., GarberJ., KaneM., KolodnerR.: The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell, 75: 1027–1038, 1993.
11.
GarceaR., DainoL., PascaleR., SimileM.S., PudduM., RuggiuM.E., SaddaiuM.A., SattaG., SequenzaM.J., FeoF.: Protooncogene methylation and expression in regenerating liver and preneoplastic liver nodules induced in the rat by diethylnitrosamine: effect of variations of S-adenosylmethio-nine: S-adenosylhomocysteine ratio. Carcinogenesis, 10: 1183–1192, 1989.
12.
GiardielloF.M., HamiltonS.R., KrushA.J., PiantadosiS., HylindL.M., CelanoP., BookerS.V., Rahj RobinsonC., Of-ferhausJ.A.: Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. N. Engl. J. Med., 328: 1313–1316, 1993.
13.
GoelzS.E., VogelsteinB., HamiltonS.R., FeinbergA.P.: Hypomethylation of DNA from benign and malignant human colon neoplasms. Science, 228: 187–190, 1985.
14.
KelvinJ.A.D. (Ed.): Oxidative damage and repair.Pergamon Press, New York, 1991.
15.
LaneD.P.: p53, guardian of the genome. Nature, 358: 15–16, 1992.
16.
LavigueurA., MaltbyV., MockD., RossantJ., PawsonT., BernsteinA.: High incidence of lung, bone and lymphoid tumors in transgenic mice overexpressing mutant alleles of the p53 oncogene. Mol. Cell. Biol., 9: 3982–3991, 1989.
17.
NakazawaH., EnglishD., RandellP.L., NakazawaK., MartelN., ArmstrongB.K., YamasakiH.: UV and skin cancer: specific p53 gene mutation in normal skin as a biologically relevant exposure measurement. Proc. Natl. Acad. Sci. USA, 91: 360–364, 1994.
18.
NicolaidesN.C., PapadopoulousN., LiuB., WeiY-F., CarterK.C., RubenS.M., RosenC.A., HaseltineW.A., FleishmannR.D., FraserC.M., AdamsM.D., VenterJ.C., DunlopM.G., HamiltonS.R., PetersenG.M., de la ChapelleA., VogelsteinB., KinzlerK.W.: Mutations of two PMS homologues in hereditary nonpolyposis colon cancer. Nature, 371: 75–80, 1994.
19.
PapadopoulousN., NicolaidesN.C., WeiY-F., RubenS.M., CarterK.C., RosenC.A., HaseltineW.A., FleischmannR.D., FraserC.M., AdamsM.D., VenterJ.C., HamiltonS.R., PetersenG.M., WatsonP., LynchH.T., PeltomFkiP., MecklinJ-P., de la ChapelleA., KinzlerK.W., VogelsteinB.: Mutation of a mutL homolog in hereditary colon cancer. Science, 263: 1625–1629, 1994.
20.
Preston-MartinS., PikeM.C., RossR.K., JonesP.A., HendersonB.E.: Increased cell division as a cause of human cancer. Cancer Res., 50: 7415–7421, 1990.
21.
SandyM.S., ChioccaS.M., CeruttiP.A.: Genotypic analysis of mutations in Taq I restriction recognition sites by restriction fragment length polymorphism/polymerase chain reaction. Proc. Natl. Acad. Sci., 89: 890–894, 1992.
22.
SidranskyD., TokinoT., HamiltonS.R., KinzlerK.W., LevinB., FrostP., VogelsteinB.: Identification of ras oncogene mutations in the stool of patients with curable colorectal tumors. Science, 256: 102–105, 1992.
